• Home
  • About Us
    • Who we are
    • Our Early History
    • Technology
    • Target Markets
      • Venous and pressure ulcers
      • Other Applications
    • Business Model
    • Licensing
    • Clinical Trial
    • Publications & Presentations
    • Company Milestones
    • Focus
  • The Company
    • Board & Management
      • Paul Wright
      • Mark Richardson
      • George Baumanis
      • Stuart Usher
  • Advisory Team
    • Intellectual Property
      • Vaughan Barlow
      • Tom Boyce
      • Audrey Yap
      • Yvette Flanigan
    • Principal Advisor
      • Mark Woolley
    • Medical and Scientific Advisory Committee
      • James Fries
      • Michael Woodward
    • Scientific
      • Richard Lipscombe
    • Clinical
      • Geoffrey Mitchell
    • Health Economics
      • Nicholas Graves
  • Media
  • Links
  • Members Log in
  • Contact Us

News Headlines

> 18/01/10
Phoenix Eagle commences clinical trial.


> 01/12/09
OPAL A-1001 clinical trial has been approved by the Human Research Ethics Committee of the Austin Hospital.

The Phoenix Eagle Board & Management

George Baumanis, Executive Director of Investor Relations

Board & Management - George Baumanis, Executive Director of Investor Relations

George is the major investor in Phoenix Eagle and as such is well qualified to take on the responsibility of Investor Relations. George is Western Australian born and educated. He graduated as a pilot in the Royal Australian Air Force in 1970, where he served for 15 years. On leaving the RAAF, George spent 20 years as a Boeing 747 Captain with Cathay Pacific Airways. George retired from flying in 2004 and returned to live in Perth and manage his varied business interests, including a commercial property development and leasing company.

The Phoenix Eagle Company Pty Ltd website is proudly maintained by NetBiz Enterprises.